COBENFY™ (xanomeline and trospium chloride) is an oral pill used for the treatment of schizophrenia in adults. See indication and Important Safety Information.

Sep 30, 2024 · Cobenfy (xanomeline and trospium chloride) is a new treatment for schizophrenia used to improve positive and negative symptoms. Cobenfy contains xanomeline, which helps …

Xanomeline/trospium chloride, sold under the brand name Cobenfy, is a fixed-dose combination medication used for the treatment of schizophrenia. [1] It contains xanomeline, a muscarinic …

Jan 6, 2025 · Antipsychotic drugs that target dopamine directly have been given to patients with schizophrenia in the form of pills, liquids, and injections since the 1950s. Cobenfy is the first of …

Jan 15, 2025 · The efficacy of COBENFY (which is a measure of how well the drug works) was evaluated in two clinical trials for 470 patients with schizophrenia, and safety was assessed in …

Sept. 27, 2024 – In a breakthrough for people living with schizophrenia, the FDA has approved a new oral medication for adults. Unlike traditional antipsychotic drugs, the medication, which …

Cobenfy (xanomeline/trospium) is commonly used to treat schizophrenia. Schizophrenia is a mental health disorder that affects a person's thinking, actions, emotions, perception of reality,...

COBENFY is indicated for the treatment of schizophrenia in adults. Assess liver enzymes and bilirubin prior to initiating COBENFY and as clinically indicated during treatment [see …

Sep 27, 2024 · Cobenfy (xanomeline/trospium chloride) could bring patients what they've long hoped for: A means of easing the hallucinations and "voices" that disrupt their lives without the …

Dec 17, 2024 · Cobenfy is a brand-name oral capsule prescribed for schizophrenia in adults. Cobenfy contains the active ingredients xanomeline and trospium chloride. Here is key …